Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Search

Page Path
HOME > Search
10 "Colorectal neoplasm"
Filter
Filter
Article category
Keywords
More +
Publication year
More +
Authors
More +
Funded articles
More +
Original Articles
No association between genetically predicted C-reactive protein levels and colorectal cancer survival in Korean: two-sample Mendelian randomization analysis
Chang Kyun Choi, Jung-Ho Yang, Min-Ho Shin, Sang-Hee Cho, Sun-Seog Kweon
Epidemiol Health. 2023;45:e2023039.   Published online March 22, 2023
DOI: https://doi.org/10.4178/epih.e2023039
  • 4,434 View
  • 165 Download
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
Elevated C-reactive protein (CRP) levels are associated with an increased risk for colorectal cancer (CRC), as well as a poor prognosis, but it remains unclear whether these associations are causal. This study examined the potential causality between CRP levels and CRC survival using 2-sample Mendelian randomization (MR).
METHODS
From the Korean Genome and Epidemiology Study, a genome-wide association study (n=59,605), 7 single-nucleotide polymorphisms (SNPs) related to log2-transformed CRP levels were extracted as instrumental variables for CRP levels. The associations between the genetically predicted CRP and CRC-specific and overall mortality among CRC patients (n=6,460) were evaluated by Aalen’s additive hazard model. The sensitivity analysis excluded a SNP related to the blood lipid profile.
RESULTS
During a median of 8.5 years of follow-up, among 6,460 CRC patients, 2,676 (41.4%) CRC patients died from all causes and 1,622 (25.1%) died from CRC. Genetically predicted CRP levels were not significantly associated with overall or CRC-specific mortality in CRC patients. The hazard difference per 1,000 person-years for overall and CRC-specific mortality per 2-fold increase in CRP levels was -2.92 (95% confidence interval [CI], -14.05 to 8.21) and -0.76 (95% CI, -9.61 to 8.08), respectively. These associations were consistent in a subgroup analysis according to metastasis and a sensitivity analysis excluding possible pleiotropic SNPs.
CONCLUSIONS
Our findings do not support a causal role for genetically predisposed CRP levels in CRC survival.
Summary
Korean summary
이 연구는 two-sample Mendelian randomization (MR)을 이용하여 대장암에서 C-reactive protein와 사망률 간의 관련성을 평가하였다. Two-sample MR은 한국유전체역학조사사업 (the Korean Genome and Epidemiology Study, KoGES) 참가자 59,605명에서 혈청 C-reactive protein에 대한 전장유전체 분석을 시행하여 7개의 단일염기다형성을 선별하였고, 화순암역학연구-대장암 (thw Hwasun Cancer Epidemiology Study-Colon and Rectum Cancer, HCES-CRC)에 등록된 6,460명 대장암 환자에서 그 7개 단일염기다형성과 사망률 간의 관련성을 평가한 결과를 이용하였다. 그 결과, 높은 혈청 C-reactive protein을 가지는 유전적 성향은 대장암 환자에서 사망률과의 통계적으로 유의한 관련성을 찾을 수 없었다.
Key Message
This study employed a two-sample Mendelian randomization (MR) analysis to investigate the relationship between serum C-reactive protein (CRP) levels and mortality in colorectal cancer. The analysis utilized genome-wide association analysis (GWAS) data from 59,605 participants in the Korean Genome and Epidemiology Study (KoGES) for serum CRP and 6,460 colorectal cancer cases from the Hwasun Cancer Epidemiology Study-Colon and Rectum Cancer for mortality. Our findings suggest that there is no statistically significant association between genetically predisposed serum CRP levels and mortality. Consequently, our study does not support a causal effect of CRP on mortality in colorectal cancer.
No evidence of delay in colorectal cancer diagnosis during the COVID-19 pandemic in Gwangju and Jeonnam, Korea
Hye-Yeon Kim, Min-Gyeong Kim, Mi-Ran Kang, Jeong-Ho Yang, Min-Ho Shin, Sun-Seog Kweon
Epidemiol Health. 2022;44:e2022092.   Published online October 17, 2022
DOI: https://doi.org/10.4178/epih.e2022092
  • 3,926 View
  • 206 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract AbstractSummary PDF
Abstract
OBJECTIVES
We evaluated whether the coronavirus disease 2019 (COVID-19) pandemic caused delays in the diagnosis and treatment of colorectal cancer (CRC) in Korea, where there have been no regional or hospital lockdowns during the pandemic period.
METHODS
Data on CRC patients (n=1,445) diagnosed in Gwangju Metropolitan City and Jeonnam Province between January 2019 and December 2021 were assessed. The stage at the time of CRC diagnosis, route to diagnosis, time to initial cancer treatment, and length of hospital admission were compared before and during the COVID-19 pandemic. Logistic regression was also performed to identify factors associated with the risk for diagnosis in an advanced stage.
RESULTS
No negative effects indicating a higher CRC stage at diagnosis or delayed treatment during the pandemic were observed. Instead, the risk for an advanced stage at diagnosis (TNM stage III/IV) decreased in CRC patients diagnosed during the pandemic (odds ratio, 0.768; 95% confidence interval, 0.647 to 0.911). No significant differences in the interval from diagnosis to operation or chemotherapy were observed.
CONCLUSIONS
No negative effects on CRC diagnosis and treatment were found until the end of 2021, which may be related to the small magnitude of the COVID-19 epidemic, the absence of a lockdown policy in Korea, and the rebound in the number of diagnostic colonoscopy procedures in 2021.
Summary
Korean summary
COVID-19 판데믹 시기에 진단된 대장암환자에서 진단병기의 지연과 치료의 지연이 발생한 증거는 찾을 수 없었다. 이것은 2021년까지 한국에서는 유행규모가 크지 않았고, 의료기관 또는 지역단위의 봉쇄정책이 거의 없었기 때문일 것으로 추정된다.
Key Message
No evidence of delayed diagnosis and treatment of colorectal cancer was found during the COVID-19 pandemic period (2020-2021) in Gwangju-Jeonnam, Korea. It may be related to the small magnitude of the COVID-19 epidemic, the absence of a lockdown policy in Korea.

Citations

Citations to this article as recorded by  
  • The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study
    Nicola L. Barclay, Marta Pineda Moncusí, Annika M. Jödicke, Daniel Prieto-Alhambra, Berta Raventós, Danielle Newby, Antonella Delmestri, Wai Yi Man, Xihang Chen, Marti Català
    Frontiers in Oncology.2024;[Epub]     CrossRef
The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea
Hyeree Park, Seung Hee Seo, Jong Heon Park, Shin Hye Yoo, Bhumsuk Keam, Aesun Shin
Epidemiol Health. 2022;44:e2022053.   Published online June 21, 2022
DOI: https://doi.org/10.4178/epih.e2022053
  • 10,633 View
  • 447 Download
  • 14 Web of Science
  • 15 Crossref
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
The coronavirus disease 2019 (COVID-19) pandemic has affected the utilization of healthcare services, including participation in cancer screening programs. We compared cancer screening participation rates for colorectal, gastric, breast, and cervical cancers among participants in the National Cancer Screening Program (NCSP) in 2019 and 2020 to address the potential distraction effect of COVID-19 on cancer screening.
METHODS
Data from the NCSP for 4 cancer types (stomach, colorectal, breast, and cervical) in 2019 and 2020 were used to calculate cancer screening participation rates by calendar month, gender, age group, and geographical region. Monthly participation rates were analyzed per 1,000 eligible individuals.
RESULTS
The screening participation rate decreased in 2020 compared to 2019 for all 4 cancers: colorectal (40.5 vs. 35.3%), gastric (61.9 vs. 54.6%), breast (63.8 vs. 55.8%), and cervical (57.8 vs. 52.2%) cancers. Following 2 major COVID-19 waves in March and December 2020, the participation rates in the 4 types of cancer screening dropped compared with those in 2019. The highest decline was observed in the elderly population aged 80 years and older (percentage change: -21% for colorectal cancer; -20% for gastric cancer; -26% for breast cancer; -20% for cervical cancer).
CONCLUSIONS
After the 2 major COVID-19 waves, the screening participation rate for 4 types of cancer declined compared with 2019. Further studies are needed to identify the indirect effects of the COVID-19 pandemic on cancer patients, such as delayed diagnoses of cancer or excess cancer deaths.
Summary
Korean summary
본 연구는 코로나 대유행 기간 전과 후 대장암, 위암, 유방암, 자궁경부암 검진 수검률 차이를 비교하고자 하였다. 첫 코로나 확진자가 발생한 2020년을 코로나 대유행 기간, 전년도 기간인 2019년을 코로나 대유행 전 기간으로 설정하며 국민건강보험공단에서 집계된 전수자료를 이용하여 암 검진 대상자 수와 수검자 수를 비교 분석하였다. 4개 암종 모두에서 2019년도와 비교하여 2020년도에 전국적으로 수검률이 감소하는 경향이 있었으며, 1차 대유행이 있었던 3월과 3차 대유행 시기인 12월에 2019년도 동기간과 비교하여 수검률이 크게 감소하였고, 80대 이상 노인 인구에서 감소폭이 다른 연령대와 비교하여 크게 나타났다.
Key Message
We found decline of the colorectal, gastric, breast and cervical cancer screening participation rates in 2020 following the two major COVID-19 waves, compared with those of 2019, and the highest decline was observed in the elderly population aged 80 years and older.

Citations

Citations to this article as recorded by  
  • Emergency department visits of newly diagnosed cardiovascular disease patients in Korea during the COVID-19 pandemic
    Ji Yoon Baek, Seung Hee Seo, Sooyoung Cho, Jun-Bean Park, Bhumsuk Keam, Shin Hye Yoo, Aesun Shin
    Scientific Reports.2024;[Epub]     CrossRef
  • Decline in Cancer Diagnoses during the ‘Zero COVID’ Policy in Hong Kong: Indirect Spillover Impact of the COVID-19 Pandemic
    H.M. Youn, Y. Zhang, A. Liu, C.S. Ng, J. Liang, G.K.K. Lau, S.F. Lee, J. Lok, C.L.K. Lam, E.Y.F. Wan, J. Quan
    Clinical Oncology.2024; 36(3): 157.     CrossRef
  • Impact of coronavirus disease 2019 on cancer care: How the pandemic has changed cancer utilization and expenditures
    Jinah Sim, Jihye Shin, Hyun Jeong Lee, Yeonseung Lee, Young Ae Kim, Chong-Chi Chiu
    PLOS ONE.2024; 19(2): e0296808.     CrossRef
  • Access to colorectal cancer screening in populations in China, 2020: A coverage‐focused synthesis analysis
    Yan‐Jie Li, Xin Wang, Yu‐Jie Wu, Xin‐Yi Zhou, Jibin Li, Jiangmei Qin, Wanghong Xu, Jie‐Bin Lew, Wanqing Chen, Ju‐Fang Shi
    International Journal of Cancer.2024;[Epub]     CrossRef
  • Analysis of the current situation and related influencing factors of cervical precancer screening under the COVID-19
    Xiaohong Song, Yongbin Yang
    Biotechnology and Genetic Engineering Reviews.2023; : 1.     CrossRef
  • Willingness to Undergo Gastroscopy for Early Gastric Cancer Screening and Its Associated Factors During the COVID-19 Pandemic – A Nationwide Cross-Sectional Study in China
    Kejia Ma, Xuejie Chen, Xin Xiang, Xueyi Mao, Ningxin Zhu, Tianyu Wang, Shuyu Ye, Xiaoyan Wang, Minzi Deng
    Patient Preference and Adherence.2023; Volume 17: 505.     CrossRef
  • Impact of coronavirus disease 2019 pandemic on breast cancer surgery using the National Database of Japan
    Misuzu Fujita, Hideyuki Hashimoto, Kengo Nagashima, Kiminori Suzuki, Tokuzo Kasai, Kazuya Yamaguchi, Yoshihiro Onouchi, Daisuke Sato, Takehiko Fujisawa, Akira Hata
    Scientific Reports.2023;[Epub]     CrossRef
  • The impact of COVID-19 pandemic on diagnosis and management of gastrointestinal cancers
    Byung Soo Yoo, Ankit Patel, Kevin V. Houston, Alejandra Vargas, Ana Rosa Vilela Sangay, Steve M. D’Souza, David A. Johnson
    Exploration of Medicine.2023; : 356.     CrossRef
  • Changes in the Utilization of Health Care Services by Cancer Patients during the COVID-19 Pandemic
    Seung Hee Seo, Sooyoung Cho, Shin Hye Yoo, Bhumsuk Keam, Aesun Shin
    Yonsei Medical Journal.2023; 64(7): 463.     CrossRef
  • The Challenges of Gastric Cancer Surgery during the COVID-19 Pandemic
    Catalin Vladut Ionut Feier, Alaviana Monique Faur, Calin Muntean, Andiana Blidari, Oana Elena Contes, Diana Raluca Streinu, Sorin Olariu
    Healthcare.2023; 11(13): 1903.     CrossRef
  • Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea
    Moonki Hong, Mingee Choi, JiHyun Lee, Kyoo Hyun Kim, Hyunwook Kim, Choong-Kun Lee, Hyo Song Kim, Sun Young Rha, Gyu Young Pih, Yoon Jin Choi, Da Hyun Jung, Jun Chul Park, Sung Kwan Shin, Sang Kil Lee, Yong Chan Lee, Minah Cho, Yoo Min Kim, Hyoung-Il Kim,
    Journal of Gastric Cancer.2023; 23(4): 574.     CrossRef
  • Socioeconomic inequality in organized and opportunistic screening for gastric cancer: results from the Korean National Cancer Screening Survey 2009–2022
    Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kui Son Choi
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Impact of the COVID-19 Pandemic on Gastric Cancer Screening in South Korea: Results From the Korean National Cancer Screening Survey (2017–2021)
    Kyeongmin Lee, Mina Suh, Jae Kwan Jun, Kui Son Choi
    Journal of Gastric Cancer.2022; 22(4): 297.     CrossRef
  • Impact of frailty on survival and readmission in patients with gastric cancer undergoing gastrectomy: A meta-analysis
    Xiaoyan Wang, Yimeng Sun, Pei Wang, Yu Jie, Guodong Liu, Dandan Gong, Yu Fan
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Trends in breast cancer screening rates among Korean women: results from the Korean National Cancer Screening Survey, 2005-2020
    Soo Yeon Song, Yun Yeong Lee, Hye Young Shin, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun
    Epidemiology and Health.2022; 44: e2022111.     CrossRef
Systematic Review
Quantifying the duration of the preclinical detectable phase in cancer screening: a systematic review
Sandra M. E. Geurts, Anne M. W. M. Aarts, André L. M. Verbeek, Tony H. H. Chen, Mireille J. M. Broeders, Stephen W. Duffy
Epidemiol Health. 2022;44:e2022008.   Published online January 3, 2022
DOI: https://doi.org/10.4178/epih.e2022008
  • 9,121 View
  • 424 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
The aim of this study was to provide an overview of published mathematical estimation approaches to quantify the duration of the preclinical detectable phase (PCDP) using data from cancer screening programs.
METHODS
A systematic search of PubMed and Embase was conducted for original studies presenting mathematical approaches using screening data. The studies were categorized by mathematical approach, data source, and assumptions made. Furthermore, estimates of the duration of the PCDP of breast and colorectal cancer were reported per study population.
RESULTS
From 689 publications, 34 estimation methods were included. Five distinct types of mathematical estimation approaches were identified: prevalence-to-incidence ratio (n=8), maximum likelihood estimation (n=16), expectation-maximization algorithm (n=1), regression of observed on expected (n=6) and Bayesian Markov-chain Monte Carlo estimation (n=5). Fourteen studies used data from both screened and unscreened populations, whereas 19 studies included only information from a screened population. Estimates of the duration of the PCDP varied between 2 years and 7 years for breast cancer in the Health Insurance Plan study (annual mammography and clinical breast examinations in women aged 40-64 years) and 2 years and 5 years for colorectal cancer in the Calvados study (a guaiac fecal occult blood test in men and women aged 45-74 years).
CONCLUSIONS
Different types of mathematical approaches lead to different estimates of the PCDP duration. We advise researchers to use the method that matches the data available, and to use multiple methods for estimation when possible, since no method is perfect.
Summary
Key Message
Quantifying the duration of the preclinical detectable phase is important for the design and evaluation of cancer screening programs. Different types of mathematical estimation approaches lead to different estimates of the preclinical detectable phase duration. We advise researchers to use the method that matches the data available, and to use multiple methods for estimation when possible, since no method is perfect.

Citations

Citations to this article as recorded by  
  • Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors
    Rikesh Bhatt, Ardo van den Hout, Antonis C. Antoniou, Mitul Shah, Lorenzo Ficorella, Emily Steggall, Douglas F. Easton, Paul D. P. Pharoah, Nora Pashayan
    Cancer.2024;[Epub]     CrossRef
  • Estimating the Length of the Preclinical Detectable Phase for Open-Angle Glaucoma
    Johan Aspberg, Anders Heijl, Boel Bengtsson
    JAMA Ophthalmology.2023; 141(1): 48.     CrossRef
Original Articles
Effect of chemotherapy and radiotherapy on cognitive impairment in colorectal cancer: evidence from Korean National Health Insurance Database Cohort
Kwanghyun Kim, Chang Woo Kim, Aesun Shin, Hyunseok Kang, Sun Jae Jung
Epidemiol Health. 2021;43:e2021093.   Published online November 2, 2021
DOI: https://doi.org/10.4178/epih.e2021093
  • 8,457 View
  • 179 Download
  • 4 Web of Science
  • 4 Crossref
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
We investigated the risk of chemotherapy-related and radiotherapy-related cognitive impairment in colorectal cancer patients.
METHODS
Medical use data of colorectal cancer patients were obtained from the Korean National Health Insurance Database from 2004 to 2018. We randomly selected 40% of all colorectal cancer patients (n=148,848). Cognitive impairment was defined as having 1 or more International Classification of Diseases, 10th revision diagnostic codes for dementia or mild cognitive impairment. Patients aged 18 years or younger, patients diagnosed with cognitive impairment before colorectal cancer diagnosis (n=8,225), and patients who did not receive primary resection (n=45,320) were excluded. The effects of individual chemotherapy regimens on cognitive impairment were estimated. We additionally estimated the effect of radiotherapy in rectal cancer patients. Time-dependent competing risk Cox regression was conducted to estimate the overall and age-specific hazard ratios (HR) separately for colon and rectal cancer. Landmark analyses with different lag times were conducted as sensitivity analyses.
RESULTS
Chemotherapy did not increase the risk of cognitive impairment in colorectal cancer patients (colon cancer: HR, 0.92; 95% confidence interval [CI], 0.83 to 1.03; rectal cancer: HR, 0.88; 95% CI, 0.75 to 1.04), while radiotherapy was negatively associated with cognitive impairment in rectal cancer patients (HR, 0.01; 95% CI, 0.84 to 0.99). Varying directions of the associations between regimens and cognitive impairment were detected. The adverse effect of certain chemotherapy regimens on cognition was more prominent in older adults.
CONCLUSIONS
Chemotherapy and radiotherapy did not increase the risk of cognitive impairment. Older patients with low cognitive reserve could be affected by the adverse cognitive effects of chemotherapy.
Summary
Korean summary
- 대장암 환자를 대상으로 한 항암화학요법 및 방사선요법은 인지기능저하의 위험을 높이지 않았다 - 일부 항암화학요법의 경우 고령의 대장암 환자에서 인지기능저하의 위험을 증가시킬 수 있다
Key Message
Results from nationwide cohort of Korea showed that chemotherapy and radiotherapy did not increase the risk of cognitive impairment in colorectal cancer patients.

Citations

Citations to this article as recorded by  
  • Predictors of cognitive impairment in patients undergoing ileostomy for colorectal cancer: a retrospective analysis
    Jing Xu, Yuelan Yang, Die Hu
    PeerJ.2023; 11: e15405.     CrossRef
  • Soluble HSPG and HS relaying neuroinflammation contribute to behavioral comorbidities associated with cancer located outside the central nervous system
    Yue-peng Liu, Yan-jun Yang
    Medical Hypotheses.2023; 177: 111113.     CrossRef
  • Chemotherapy-induced functional brain abnormality in colorectal cancer patients: a resting‐state functional magnetic resonance imaging study
    Siwen Liu, Yesong Guo, Jie Ni, Na Yin, Chenchen Li, Xuan Pan, Rong Ma, Jianzhong Wu, Shengwei Li, Xiaoyou Li
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Association between multimorbidity status and incident dementia: a prospective cohort study of 245,483 participants
    He-Ying Hu, Ya-Ru Zhang, Qiaolifan Aerqin, Ya-Nan Ou, Zuo-Teng Wang, Wei Cheng, Jian-Feng Feng, Lan Tan, Jin-Tai Yu
    Translational Psychiatry.2022;[Epub]     CrossRef
The classification capability of the Asia Pacific Colorectal Screening score in Korea: an analysis of the Cancer Screenee Cohort
Xuan Quy Luu, Kyeongmin Lee, Jeongseon Kim, Dae Kyung Sohn, Aesun Shin, Kui Son Choi
Epidemiol Health. 2021;43:e2021069.   Published online September 16, 2021
DOI: https://doi.org/10.4178/epih.e2021069
  • 8,005 View
  • 215 Download
  • 4 Web of Science
  • 6 Crossref
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
This study aimed to validate a simple risk assessment tool for estimating the advanced colorectal neoplasia (ACN) risk at colonoscopy screenings and potential factors relevant for implementing this tool in the Korean population.
METHODS
Our study analyzed data from the Cancer Screenee Cohort Study conducted by the National Cancer Center in Korea. The risk level was assessed using the Asia Pacific Colorectal Screening (APCS) score developed by the Asia-Pacific Working Group on Colorectal Cancer. Logistic regression models were used to examine the associations between colorectal-related outcomes and the risk level by APCS score. The discriminatory performance of the APCS score for various colorectal-related outcomes was assessed using C-statistics.
RESULTS
In 12,520 individuals, 317 ACN cases and 4,528 adenoma cases were found. The APCS tool successfully classified the study population into different risk groups, and significant differences in the ACN rate and other outcomes were observed. The APCS score demonstrated acceptable discrimination capability with area under the curve values ranging from 0.62 to 0.65 for various outcomes. The results of the multivariate logistic regression model revealed that the high-risk group had a 3.1-fold higher risk of ACN (95% confidence interval, 2.08 to 4.67) than the average-risk group. Body mass index (BMI) was identified as a significant predictor of ACN in both multivariate and subgroup analyses.
CONCLUSIONS
Our study highlighted significant differences in colorectal-related screening outcomes by colorectal risk level measured using the APCS score, and BMI could be used to improve the discriminatory capability of the APCS score.
Summary
Korean summary
검진의 위해성을 줄이면서 동시에 이득을 최대화할 수 있는 최적의 검진 프로그램은 암 발생 위험도를 고려하는 것이다. 이 연구는 Asia-Pacific Working Group on Colorectal Cancer에서 제안한 “Asia Pacific Colorectal Screening Score (APCS)”가 한국인에서 대장암 발생 위험도를 선별적으로 잘 구분해 낼 수 있음을 보여주었다. 나아가 대장암의 위험도 점수를 산출하는데 체질량지수가 중요한 예측 변수라는 것을 확인하였고, 한국인에서 대장암 발생 위험도의 변별력을 향상시키기 위해 기존의 APCS에 체질량지수를 추가할 것을 제안하였다.
Key Message
This study highlighted that the Asia Pacific Colorectal Screening Score by the Asia-Pacific Working Group on Colorectal Cancer could successfully classify Korean screenees into different risk groups with acceptable discriminatory capability. Furthermore, our study results also suggest that BMI is a significant predictor of colorectal-related health outcomes, which could be potentially added to the original APCS score for improving its discriminatory power.

Citations

Citations to this article as recorded by  
  • Performance of the Asia–Pacific Colorectal Screening score in stratifying the risk of advanced colorectal neoplasia: A meta‐analysis and systematic review
    Mai Ngoc Luu, Nhi Ai Trinh, Truc Le Thanh Tran, Thinh Phuong Dang, Toru Hiyama, Duc Trong Quach
    Journal of Gastroenterology and Hepatology.2024;[Epub]     CrossRef
  • A Comparison of Single and Combined Schemes of Asia-Pacific Colorectal Screening, Faecal Immunochemical and Stool Deoxyribonucleic Acid Testing for Community Colorectal Cancer Screening
    Yuan Ze, Huiming Tu, Lin Zhang, Yu Bai, Yilin Ren, Xin Chen, Yuzheng Xue, Renjuan Sun, Yuling Yang, Jie Yang, Xuan Zhou, Li Liu
    Journal of Multidisciplinary Healthcare.2023; Volume 16: 571.     CrossRef
  • Advances in Screening Methods for Colorectal Cancer
    碗宜 张
    Advances in Clinical Medicine.2023; 13(03): 2995.     CrossRef
  • From Algorithms to Clinical Utility: A Systematic Review of Individualized Risk Prediction Models for Colorectal Cancer
    Deborah Jael Herrera, Wessel van de Veerdonk, Daiane Maria Seibert, Moges Muluneh Boke, Claudia Gutiérrez-Ortiz, Nigus Bililign Yimer, Karen Feyen, Allegra Ferrari, Guido Van Hal
    Gastrointestinal Disorders.2023; 5(4): 549.     CrossRef
  • Socioeconomic inequality in organized and opportunistic screening for colorectal cancer: results from the Korean National Cancer Screening Survey, 2009-2021
    Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kui Son Choi
    Epidemiology and Health.2023; 45: e2023086.     CrossRef
  • A scoping review of risk-stratified bowel screening: current evidence, future directions
    J. M. Cairns, S. Greenley, O. Bamidele, D. Weller
    Cancer Causes & Control.2022; 33(5): 653.     CrossRef
Geographic distribution of the incidence of colorectal cancer in Iran: a population-based study
Fatemeh Khosravi Shadmani, Erfan Ayubi, Salman Khazaei, Mohadeseh Sani, Shiva Mansouri Hanis, Somayeh Khazaei, Mokhtar Soheylizad, Kamyar Mansori
Epidemiol Health. 2017;39:e2017020.   Published online May 17, 2017
DOI: https://doi.org/10.4178/epih.e2017020
  • 15,919 View
  • 280 Download
  • 27 Web of Science
  • 25 Crossref
AbstractAbstract PDF
Abstract
OBJECTIVES
Colorectal cancer (CRC) is the third most common cancer and the fourth most common cause of cancer death in the world. The aim of this study was to investigate the provincial distribution of the incidence of CRC across Iran.
METHODS
This epidemiologic study used data from the National Cancer Registry of Iran and the Center for Disease Control and Prevention of the Ministry of Health and Medical Education of Iran. The average annual age-standardized rate (ASR) for the incidence of CRC was calculated for each province.
RESULTS
We found that adenocarcinoma (not otherwise specified) was the most common histological subtype of CRC in males and females, accounting for 81.91 and 81.95% of CRC cases, respectively. Signet ring cell carcinoma was the least prevalent subtype of CRC in males and females and accounted for 1.5 and 0.94% of CRC cases, respectively. In patients aged 45 years or older, there was a steady upward trend in the incidence of CRC, and the highest ASR of CRC incidence among both males and females was in the age group of 80-84 years, with an ASR of 144.69 per 100,000 person-years for males and 119.18 per 100,000 person-years for females. The highest incidence rates of CRC in Iran were found in the central, northern, and western provinces. Provinces in the southeast of Iran had the lowest incidence rates of CRC.
CONCLUSIONS
Wide geographical variation was found in the incidence of CRC across the 31 provinces of Iran. These variations must be considered for prevention and control programs for CRC, as well as for resource allocation purposes.
Summary

Citations

Citations to this article as recorded by  
  • A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016
    Mohammad Abolhosseini, Zahra Khorrami, Sare Safi, Mohammad Esmaeil Akbari, Seyed Mohamadmehdi Moshtaghion, Seyed Farzad Mohammadi, Mozhgan Rezaei Kanavi, Saeed Karimi
    Scientific Reports.2023;[Epub]     CrossRef
  • Outcome of early versus late ileostomy closure in patients with rectal cancers undergoing low anterior resection: A prospective cohort study
    Alimohammad Bananzade, Maryam Dehghankhalili, Faranak Bahrami, Seyed Mohammad Kazem Tadayon, Fariborz Ghaffarpasand
    Asian Journal of Surgery.2023; 46(10): 4277.     CrossRef
  • Carbohydrate quality indices and colorectal cancer risk: a case-control study
    Masoud Amini Kahrizsangi, Zohreh Ebrahimi, Zainab Shateri, Fatemeh Mansouri, Ali Zangene, Milad Rajabzadeh-Dehkordi, Mehran Nouri, Bahram Rashidkhani
    BMC Cancer.2023;[Epub]     CrossRef
  • Impacts of some clinicopathodemography and colorectal tissues key cell cycle and mucin stabilizing molecules on the metastasis trend in colorectal cancer patients
    Ali Ghorbani Ranjbary, Jalil Mehrzad, Nasrollah Rahbar, Hesam Dehghani
    Molecular Biology Reports.2023; 50(10): 8589.     CrossRef
  • Evaluation of correlation of miR-141 expression changes with common mutations of K-Ras gene and its relationship with prognosis in tumor tissue of colorectal cancer in Iranian patients
    Melika Arkani, Ardeshir Hesampour Mahallati, Maliheh Entezari
    Medical Sciences Journal of Islamic Azad University.2023; 33(3): 230.     CrossRef
  • Serum level and tumor tissue expression of Ribonucleotide-diphosphate Reductase subunit M2 B: a potential biomarker for colorectal cancer
    Naser Mobarra, Hanieh Gholamalizadeh, Kaed A. Abdulhussein, Sara Raji, Fatemeh Taheri Asl, Mobina Sadat Mirvahabi, Mahdi Rafiee, Reza Pakzad
    Molecular Biology Reports.2022; 49(5): 3657.     CrossRef
  • Enhanced anticancer potency with reduced nephrotoxicity of newly synthesized platin-based complexes compared with cisplatin
    Roya Salehi, Selda Abyar, Fatemeh Ramazani, Ali Akbar Khandar, Seyed Abolfazl Hosseini-Yazdi, Jonathan M. White, Mahdi Edalati, Houman Kahroba, Mehdi Talebi
    Scientific Reports.2022;[Epub]     CrossRef
  • A systematic review of methods to estimate colorectal cancer incidence using population-based cancer registries
    Norah Alsadhan, Alaa Almaiman, Mar Pujades-Rodriguez, Cathy Brennan, Farag Shuweihdi, Sultana A. Alhurishi, Robert M. West
    BMC Medical Research Methodology.2022;[Epub]     CrossRef
  • Evaluation of lymph node adequacy in patients with colorectal cancer: Results from a referral center in Iran
    Hossein Yahyazadeh, Ahmad Rezazadeh Mafi, Marzieh Beheshti, Amin Ghareyazi, Azita Abdollahinejad, Sahel Valadan Tahbaz
    Forum of Clinical Oncology.2022;[Epub]     CrossRef
  • Evaluation of lymph node adequacy in patients with colorectal cancer: Results from a referral center in Iran
    Hossein Yahyazadeh, Ahmad Rezazadeh Mafi, Marzieh Beheshti, Amin Ghareyazi, Azita Abdollahinejad, Sahel Valadan Tahbaz
    Forum of Clinical Oncology.2022; 13(1): 9.     CrossRef
  • Diet-dependent acid load and the risk of colorectal cancer and adenoma: a case–control study
    Saeede Jafari Nasab, Pegah Rafiee, Alireza Bahrami, Nasim Rezaeimanesh, Bahram Rashidkhani, Golbon Sohrab, Farah Naja, Ehsan Hejazi, Amir Sadeghi
    Public Health Nutrition.2021; 24(14): 4474.     CrossRef
  • Incidence and Risk Factors of Colorectal Cancer in the Iranian Population: a Systematic Review
    Hossein Mozafar Saadati, Batool Okhovat, Farzad Khodamoradi
    Journal of Gastrointestinal Cancer.2021; 52(2): 414.     CrossRef
  • Trends of Colorectal Cancer Epidemiology and Morphology in Tehran Metropolis, Iran from 2006 to 2015
    Mehdi Azizmohammad Looha, Gohar Mohammadi, Mohammad Esmaeil Akbari, Elham Partovipour, Majid Samsami
    International Journal of Cancer Management.2021;[Epub]     CrossRef
  • Participation Rate, Risk Factors, and Incidence of Colorectal Cancer in the Screening Program Among the Population Covered by the Health Centers in Arak, Iran
    Pegah Mohaghegh, Farzane Ahmadi, Mahjabin Shiravandi, Javad Nazari
    International Journal of Cancer Management.2021;[Epub]     CrossRef
  • A case-control study of Dietary Approaches to Stop Hypertension (DASH) diets, colorectal cancer and adenomas among Iranian population
    Saeede Jafari Nasab, Matin Ghanavati, Pegah Rafiee, Alireza Bahrami, Nazanin Majidi, Cain C. T. Clark, Amir Sadeghi, Mohammad Houshyari, Ehsan Hejazi
    BMC Cancer.2021;[Epub]     CrossRef
  • The Association of Fat-Mass-and Obesity-Associated Gene Polymorphism (rs9939609) With Colorectal Cancer: A Case-Control Study
    Maryam Gholamalizadeh, Mohammad Esmail Akbari, Saeid Doaei, Sayed Hossein Davoodi, Bojlul Bahar, Ghasem Azizi Tabesh, Hossein Sadeghi, Melika Razavi Hashemi, Elham Kheyrani, Samira Rastgoo, Azadeh Hajipour, Zahra Aslany, Reza Mirfakhraie, Alireza Mosavi J
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Premature mortality of gastrointestinal cancer in Iran: trends and projections 2001–2030
    Fatemeh Khosravi Shadmani, Farshad Farzadfar, Moein Yoosefi, Kamyar Mansori, Reza Khosravi Shadman, Aliakbar Haghdoost
    BMC Cancer.2020;[Epub]     CrossRef
  • Measuring inequalities in the selected indicators of National Health Accounts from 2008 to 2016: evidence from Iran
    Mohammad Hossein Mehrolhassani, Vahid Yazdi-Feyzabadi, Marzieh Lashkari
    Cost Effectiveness and Resource Allocation.2020;[Epub]     CrossRef
  • Spatio-temporal analysis of colorectal cancer using a geographic information system in the Iranian military community during the period 2007–2016
    Alireza Khoshdel, M Alimohammadi, M Sepandi, Y Alimohamadi, P Jalali, M Janani
    BMJ Military Health.2020; 166(E): e8.     CrossRef
  • Positive correlation between interleukin-1 receptor antagonist gene 86bp VNTR polymorphism and colorectal cancer susceptibility: a case-control study
    Mostafa Ibrahimi, Maryam Moossavi, Ehsan Nazemalhosseini Mojarad, Mahsa Musavi, Milad Mohammadoo-khorasani, Zahra Shahsavari
    Immunologic Research.2019; 67(1): 151.     CrossRef
  • Lymphovascular and Perineural Invasions Are Independently Associated with Advanced Colorectal Carcinoma
    Hossein Yahyazadeh, Ahmad R Mafi, Elham Khatooni, Marzieh Beheshti, Azita Abdollahinejad
    International Journal of Cancer Management.2019;[Epub]     CrossRef
  • The Prediction of Colorectal Cancer Screening Based on the Extended Parallel Process Model: Moderating the Role of Health Literacy and Cancer-Related Empowerment
    Isaac Rahimian Boogar, Siavash Talepasand, Hassan Norouzi, Sara Mozafari, Sayed Javad Hosseini
    International Journal of Cancer Management.2018;[Epub]     CrossRef
  • Synthesis of Cyanoenone-Modified Diterpenoid Analogs as Novel Bmi-1-Mediated Antitumor Agents
    Lian-Fang Yang, Yajing Xing, Jie-Xin Xiao, Jia Xie, Wei Gao, Jiuqing Xie, Li-Ting Wang, Jinhua Wang, Mingyao Liu, Zhengfang Yi, Wen-Wei Qiu
    ACS Medicinal Chemistry Letters.2018; 9(11): 1105.     CrossRef
  • Bayesian adjustment for trend of colorectal cancer incidence in misclassified registering across Iranian provinces
    Sajad Shojaee, Nastaran Hajizadeh, Hadis Najafimehr, Luca Busani, Mohamad Amin Pourhoseingholi, Ahmad Reza Baghestani, Maryam Nasserinejad, Sara Ashtari, Mohammad Reza Zali, Hassan Ashktorab
    PLOS ONE.2018; 13(12): e0199273.     CrossRef
  • Prognostic significance of the tumor-stroma ratio in colon carcinoma: a retrospective study
    Özgen Arslan Solmaz
    Archives of Medical Science – Civilization Diseases.2018; 3(1): 190.     CrossRef
Brief Communication
Incidence and mortality rates of colorectal cancer in Malaysia
Muhammad Radzi Abu Hassan, Ibtisam Ismail, Mohd Azri Mohd Suan, Faizah Ahmad, Wan Khamizar Wan Khazim, Zabedah Othman, Rosaida Mat Said, Wei Leong Tan, Siti Rahmah @ Noor Syahireen Mohammed, Shahrul Aiman Soelar, Nik Raihan Nik Mustapha
Epidemiol Health. 2016;38:e2016007.   Published online March 9, 2016
DOI: https://doi.org/10.4178/epih.e2016007
  • 27,525 View
  • 574 Download
  • 27 Web of Science
  • 25 Crossref
AbstractAbstract PDF
Abstract
OBJECTIVES
This is the first study that estimates the incidence and mortality rate for colorectal cancer (CRC) patients in Malaysia by sex and ethnicity.
METHODS
The 4,501 patients were selected from National Cancer Patient Registry-Colorectal Cancer data. Patient survival status was cross-checked with the National Registration Department. The age-standardised rate (ASR) was calculated as the proportion of CRC cases (incidence) and deaths (mortality) from 2008 to 2013, weighted by the age structure of the population, as determined by the Department of Statistics Malaysia and the World Health Organization world standard population distribution.
RESULTS
The overall incidence rate for CRC was 21.32 cases per 100,000. Those of Chinese ethnicity had the highest CRC incidence (27.35), followed by the Malay (18.95), and Indian (17.55) ethnicities. The ASR incidence rate of CRC was 1.33 times higher among males than females (24.16 and 18.14 per 100,000, respectively). The 2011 (44.7%) CRC deaths were recorded. The overall ASR of mortality was 9.79 cases, with 11.85 among the Chinese, followed by 9.56 among the Malays and 7.08 among the Indians. The ASR of mortality was 1.42 times higher among males (11.46) than females (8.05).
CONCLUSIONS
CRC incidence and mortality is higher in males than females. Individuals of Chinese ethnicity have the highest incidence of CRC, followed by the Malay and Indian ethnicities. The same trends were observed for the age-standardised mortality rate.
Summary

Citations

Citations to this article as recorded by  
  • Anti-Cancer Mechanisms of Diarylpentanoid MS17 (1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one) in Human Colon Cancer Cells: A Proteomics Approach
    Kha Wai Hon, Syafiq Asnawi Zainal Abidin, Faridah Abas, Iekhsan Othman, Rakesh Naidu
    International Journal of Molecular Sciences.2024; 25(6): 3503.     CrossRef
  • Whole genome sequencing of Malaysian colorectal cancer patients reveals specific druggable somatic mutations
    Ryia Illani Mohd Yunos, Nurul-Syakima Ab Mutalib, Jia-shiun Khoo, Sazuita Saidin, Muhiddin Ishak, Saiful Effendi Syafruddin, Francis Yew Fu Tieng, Najwa Farhah Md Yusof, Mohd Ridhwan Abd Razak, Norshahidah Mahamad Nadzir, Nadiah Abu, Isa Md Rose, Ismail S
    Frontiers in Molecular Biosciences.2023;[Epub]     CrossRef
  • The Potential Chemopreventive Effect of Andrographis paniculata on 1,2-Dimethylhydrazine and High-Fat-Diet-Induced Colorectal Cancer in Sprague Dawley Rats
    Tharani Subarmaniam, Rusydatul Nabila Mahmad Rusli, Kokila Vani Perumal, Yoke Keong Yong, Siti Hadizah, Fezah Othman, Khaled Salem, Nurul Husna Shafie, Rosnani Hasham, Khoo Boon Yin, Khairul Kamilah Abdul Kadir, Hasnah Bahari, Zainul Amiruddin Zakaria
    International Journal of Molecular Sciences.2023; 24(6): 5224.     CrossRef
  • Dentatin triggers ROS-mediated apoptosis, G0/G1 cell cycle arrest and release of Th1-related cytokines in colorectal carcinoma cells
    Ahmad Khusairy Zulpa, Barathan Muttiah, Kumutha Malar Vellasamy, Vanitha Mariappan, Jamuna Vadivelu
    Journal of Taibah University for Science.2023;[Epub]     CrossRef
  • Antiproliferative Activities of Acetone Extract From Canarium Odontophyllum (Dabai) Stem Bark Against Human Colorectal Cancer Cells
    Siti Fairuz Ishak, Nor Fadilah Rajab, Dayang Fredalina Basri
    Dose-Response.2023; 21(2): 155932582210989.     CrossRef
  • Glycoproteomics-based liquid biopsy: translational outlook for colorectal cancer clinical management in Southeast Asia
    Gaayathri Kumarasamy, Nurul Hakimah Mohd Salim, Nur Syafiqah Mohd Afandi, Mohd Afiq Hazlami Habib, Nor Datiakma Mat Amin, Mohd Nazri Ismail, Marahaini Musa
    Future Oncology.2023; 19(34): 2313.     CrossRef
  • Colorectal cancer survival among Malaysia population: data from the Malaysian National Cancer Registry
    Nor Asiah Muhamad, Nur Hasnah Ma’amor, Izzah Athirah Rosli, Fatin Norhasny Leman, Mohd Hatta Abdul Mutalip, Huan-Keat Chan, Siti Norbayah Yusof, Nor Saleha Ibrahim Tamin, Tahir Aris, Nai Ming Lai, Muhammad Radzi Abu Hassan
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Prognostic Factors for Survival of Colorectal Adenocarcinoma Patients in Uganda
    Richard Wismayer, Julius Kiwanuka, Henry Wabinga, Michael Odida
    Cancer Management and Research.2022; Volume 14: 875.     CrossRef
  • A systematic review of methods to estimate colorectal cancer incidence using population-based cancer registries
    Norah Alsadhan, Alaa Almaiman, Mar Pujades-Rodriguez, Cathy Brennan, Farag Shuweihdi, Sultana A. Alhurishi, Robert M. West
    BMC Medical Research Methodology.2022;[Epub]     CrossRef
  • TCGA-My: A Systematic Repository for Systems Biology of Malaysian Colorectal Cancer
    Mohd Amin Azuwar, Nor Azlan Nor Muhammad, Nor Afiqah-Aleng, Nurul-Syakima Ab Mutalib, Najwa Farhah Md. Yusof, Ryia Illani Mohd Yunos, Muhiddin Ishak, Sazuita Saidin, Isa Mohamed Rose, Ismail Sagap, Luqman Mazlan, Zairul Azwan Mohd Azman, Musalmah Mazlan,
    Life.2022; 12(6): 772.     CrossRef
  • The survival impact of palliative chemotherapy dose modifications on metastatic colon cancer
    Mohd Naqib Zainal Abidin, Marhanis Salihah Omar, Farida Islahudin, Noraida Mohamed Shah
    BMC Cancer.2022;[Epub]     CrossRef
  • Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer
    Muhammad Afiq Osman, Hui-min Neoh, Nurul-Syakima Ab Mutalib, Siok-Fong Chin, Luqman Mazlan, Raja Affendi Raja Ali, Andee Dzulkarnaen Zakaria, Chai Soon Ngiu, Mia Yang Ang, Rahman Jamal
    Scientific Reports.2021;[Epub]     CrossRef
  • Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002–09 and 2010–17
    Shirley H. F. Lee, Hanif Abdul Rahman, Nadiah Abidin, Sok King Ong, Elvynna Leong, Lin Naing
    BMC Cancer.2021;[Epub]     CrossRef
  • Nanoparticles and Gut Microbiota in Colorectal Cancer
    Komathi Perumal, Suhana Ahmad, Manali Haniti Mohd-Zahid, Wan Nurhidayah Wan Hanaffi, Iskander Z.A., Jean-Luc Six, Khalid Ferji, Juhana Jaafar, Jennifer C. Boer, Magdalena Plebanski, Vuk Uskoković, Rohimah Mohamud
    Frontiers in Nanotechnology.2021;[Epub]     CrossRef
  • Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
    T. Yoshino, G. Argilés, E. Oki, E. Martinelli, H. Taniguchi, D. Arnold, S. Mishima, Y. Li, B.K. Smruti, J.B. Ahn, I. Faud, C.E. Chee, K.-H. Yeh, P.-C. Lin, C. Chua, H.H. Hasbullah, M.A. Lee, A. Sharma, Y. Sun, G. Curigliano, H. Bando, F. Lordick, T. Yaman
    Annals of Oncology.2021; 32(12): 1496.     CrossRef
  • Incidence and clinicopathological features of colorectal cancer among multi-ethnic patients in Kuala Lumpur, Malaysia: a hospital-based retrospective analysis over two decades
    Khairul Najmi Muhammad Nawawi, Norfilza M. Mokhtar, Zhiqin Wong, Zairul Azwan Mohd Azman, Deborah Chia Hsin Chew, Rasyidah Rehir, Jocelyn Leong, Fuad Ismail, Isa Mohamed Rose, Yazmin Yaacob, Hamzaini Abdul Hamid, Ismail Sagap, Raja Affendi Raja Ali
    PeerJ.2021; 9: e12425.     CrossRef
  • Clinicopathological patterns and survival outcomes of colorectal cancer among young adults in Malaysia: an institutional cohort study
    SW Wong, DY Ling, RQ Yeow, RW Chong, R Aziz, NA Aziz, KS Poh, AC Roslani
    Singapore Medical Journal.2021; 62(12): 636.     CrossRef
  • Prevalence and association of pks+ Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia
    Thevambiga Iyadorai, Vanitha Mariappan, Kumutha Malar Vellasamy, Jane Wangui Wanyiri, April Camilla Roslani, Goh Khean Lee, Cynthia Sears, Jamuna Vadivelu, Emiko Mizoguchi
    PLOS ONE.2020; 15(1): e0228217.     CrossRef
  • SURVIVAL OF PATIENTS WITH COLORECTAL CANCER IN A CANCER CENTER
    Samuel AGUIAR JUNIOR, Max Moura de OLIVEIRA, Diego Rodrigues Mendonça e SILVA, Celso Abdon Lopes de MELLO, Vinicius Fernando CALSAVARA, Maria Paula CURADO
    Arquivos de Gastroenterologia.2020; 57(2): 172.     CrossRef
  • Synthesis, characterisation of new derivatives with mono ring system of 1,2,4-triazole scaffold and their anticancer activities
    Mukhlif Mohsin Slaihim, Fouad Saleih R. Al-Suede, Melati Khairuddean, Mohamed B. Khadeer Ahamed, Amin Malik Shah Abdul Majid
    Journal of Molecular Structure.2019;[Epub]     CrossRef
  • The Rise of Colorectal Cancer in Asia: Epidemiology, Screening, and Management
    Elias F. Onyoh, Wen-Feng Hsu, Li-Chun Chang, Yi-Chia Lee, Ming-Shiang Wu, Han-Mo Chiu
    Current Gastroenterology Reports.2019;[Epub]     CrossRef
  • Prevalence and risk factors of colorectal cancer in Asia
    Martin CS Wong, Hanyue Ding, Jingxuan Wang, Paul SF Chan, Junjie Huang
    Intestinal Research.2019; 17(3): 317.     CrossRef
  • LOC285629 regulates cell proliferation and motility in colorectal cancer cells
    S. N. Nasir, N. Abu, N. S. Ab Mutalib, M. Ishak, I. Sagap, L. Mazlan, I. M. Rose, R. Jamal
    Clinical and Translational Oncology.2018; 20(6): 775.     CrossRef
  • Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital
    Bello Arkilla Magaji, Foong Ming Moy, April Camilla Roslani, Chee Wei Law
    BMC Cancer.2017;[Epub]     CrossRef
  • Geographic distribution of the incidence of colorectal cancer in Iran: a population-based study
    Fatemeh Khosravi Shadmani, Erfan Ayubi, Salman Khazaei, Mohadeseh Sani, Shiva Mansouri Hanis, Somayeh Khazaei, Mokhtar Soheylizad, Kamyar Mansori
    Epidemiology and Health.2017; 39: e2017020.     CrossRef
Health Statistics
Changing trends in colorectal cancer in the Republic of Korea: contrast with Japan
Minjoo Yoon, Nicholas Kim, Byungho Nam, Jungnam Joo, Moran Ki
Epidemiol Health. 2015;37:e2015038.   Published online August 17, 2015
DOI: https://doi.org/10.4178/epih/e2015038
  • 22,213 View
  • 313 Download
  • 19 Web of Science
  • 17 Crossref
AbstractAbstract AbstractSummary PDF
Abstract
Colorectal cancer has a high worldwide incidence. Japan, a country that is geographically and culturally similar to the Republic of Korea (here after Korea), has recently reported a decreasing trend in the incidence of colorectal cancer. However, Korea had the highest incidence of colorectal cancer among Asian countries in 2012. Our aim was to observe the changing trends in incidence and mortality of colorectal cancer in Korea and to compare them to those in Japan. Incidence data were collected from the Korean Central Cancer Registry and mortality data were collected from Korean Statistical Information Service. Incidence and mortality data on colorectal cancer in Japan were acquired from the National Cancer Center in Japan. Age-standardized incidence and mortality rates were determined based on Segi’s world population. Screening data from both countries were collected from the national cancer center in each country. In Korea, the age-standardized incidence rate of colorectal cancer in both sexes was 20.9 to 38.0 per 100,000 from 1999 to 2012 and the rate in males increased more dramatically than in females. In addition, the increase between 2002 and 2012 was first observed in the age group over 40. In Japan, the incidence of colorectal cancer has been more constant over recent years than in Korea. The age-standardized mortality rate of colorectal cancer in both sexes in Korea was 8.5 to 9.3 per 100,000 from 2000 to 2013, and the trend in mortality was constant during this period. In Japan, the mortality rate decreased slightly during the same period. Crude screening rates were increased overall in both Korea and Japan during the period studied. Since the incidence of colorectal cancer has increased in Korea, the control of this cancer is an important public health issue. As Japan has achieved a reduction in colorectal cancer, adjustment of Korea’s current systems for screening and treatment of colorectal cancer according to those of Japan may contribute to improved colorectal cancer control in Korea.
Summary
Korean summary
우리나라와 지리적, 문화적으로 가까운 일본은 대장암 발생 및 사망이 감소하고 있는 반면, 한국의 대장암 발생은 증가하는 추세이다. 본 연구는 한국의 대장암 발생 및 사망의 경향을 관찰하고, 이를 일본의 경우와 비교하고자 한다

Citations

Citations to this article as recorded by  
  • Self-expandable metallic stents as a bridge to surgery in obstructive right- and left-sided colorectal cancer: a multicenter cohort study
    Eui Myung Kim, Jun Ho Park, Byung Chun Kim, Il Tae Son, Jeong Yeon Kim, Jong Wan Kim
    Scientific Reports.2023;[Epub]     CrossRef
  • A systematic review of methods to estimate colorectal cancer incidence using population-based cancer registries
    Norah Alsadhan, Alaa Almaiman, Mar Pujades-Rodriguez, Cathy Brennan, Farag Shuweihdi, Sultana A. Alhurishi, Robert M. West
    BMC Medical Research Methodology.2022;[Epub]     CrossRef
  • SK1 Inhibitor RB005 Induces Apoptosis in Colorectal Cancer Cells through SK1 Inhibition Dependent and Independent Pathway
    Jitendra Shrestha, Maftuna Shamshiddinova, Yong-Moon Lee, Yoon Sin Oh, Dong Jae Baek, Eun-Young Park
    Current Molecular Pharmacology.2022; 15(3): 570.     CrossRef
  • Statistical methods for measuring trends in colorectal cancer incidence in registries: A systematic review
    Norah Alsadhan, Alaa Almaiman, Mar Pujades-Rodriguez, Cathy Brennan, Farag Shuweihdi, Sultana A. Alhurishi, Robert M. West
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Awareness, attitude and barriers of colorectal cancer screening among high-risk populations in China: a cross-sectional study
    Ruo-lin Huang, Qi Liu, Ying-xin Wang, Jin-yu Zou, Li-feng Hu, Wen Wang, Ying-hui Huang, Yi-zhuo Wang, Bo Zeng, Xi Zeng, Ying Zeng
    BMJ Open.2021; 11(7): e045168.     CrossRef
  • An age-period-cohort analysis of mortality rates for stomach, colorectal, liver, and lung cancer among prefectures in Japan, 1999–2018
    Tasuku Okui
    Environmental Health and Preventive Medicine.2020;[Epub]     CrossRef
  • Regional Differences in Colorectal Cancer Mortality Between 2000 and 2013 in Republic of Korea
    Hyeong Taek Woo, Jin Ah Sim, Jonghoon Mo, Young Ho Yun, Aesun Shin
    Journal of Epidemiology.2019; 29(10): 399.     CrossRef
  • Oncologic Outcomes of Postoperative Chemoradiotherapy Versus Chemotherapy Alone in Stage II and III Upper Rectal Cancer
    Ji Eun Yoon, Soo Young Lee, Han Duk Kwak, Seung Seop Yeom, Chang Hyun Kim, Jae Kyun Joo, Hyeong Rok Kim, Young Jin Kim
    Annals of Coloproctology.2019; 35(3): 137.     CrossRef
  • Long-term outcomes after stenting as a bridge to surgery in patients with obstructing left-sided colorectal cancer
    Jihye Park, Hyun Jung Lee, Soo Jung Park, Hyuk Hur, Byung Soh Min, Jae Hee Cheon, Tae Il Kim, Nam Kyu Kim, Won Ho Kim
    International Journal of Colorectal Disease.2018; 33(6): 799.     CrossRef
  • Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence
    Jihye Park, Jae Hyun Kim, Yehyun Park, Soo Jung Park, Jae Hee Cheon, Won Ho Kim, Ji Soo Park, Justin Y. Jeon, Tae Il Kim, John Green
    PLOS ONE.2018; 13(3): e0193753.     CrossRef
  • Cause-of-death statistics in 2016 in the Republic of Korea
    Hyun-Young Shin, Ji-Youn Lee, Jee-Eun Kim, Seokmin Lee, Heejo Youn, Heyran Kim, Jeonghun Lee, Min Sim Park, Sun Huh
    Journal of the Korean Medical Association.2018; 61(9): 573.     CrossRef
  • Maternal stress and early-onset colorectal cancer
    Qi Zhang, Franklin G. Berger, Bryan Love, Carolyn E. Banister, Elizabeth A. Murphy, Lorne J. Hofseth
    Medical Hypotheses.2018; 121: 152.     CrossRef
  • Germline Variants in MLH1, MSH2, and MSH6 in Korean Patients with Lynch Syndrome
    Kyoung-Jin Park, Dong Kyung Chang, Hee Cheol Kim, Jong-Won Kim
    Laboratory Medicine Online.2018; 8(4): 156.     CrossRef
  • Willingness to pay for colorectal cancer screening in Guangzhou
    Qin Zhou, Yan Li, Hua-Zhang Liu, Ying-Ru Liang, Guo-Zhen Lin
    World Journal of Gastroenterology.2018; 24(41): 4708.     CrossRef
  • Risk factors of nonadherence to colonoscopy surveillance after polypectomy and its impact on clinical outcomes: a KASID multicenter study
    Chung Hyun Tae, Chang Mo Moon, Seong-Eun Kim, Sung-Ae Jung, Chang Soo Eun, Jae Jun Park, Geom Seog Seo, Jae Myung Cha, Sung Chul Park, Jaeyoung Chun, Hyun Jung Lee, Yunho Jung, Jin Oh Kim, Young-Eun Joo, Dong Il Park
    Journal of Gastroenterology.2017; 52(7): 809.     CrossRef
  • The Incidence and Mortality of Colorectal Cancer and Its Relationship With the Human Development Index in Asia
    Mahshid Ghoncheh, Maryam Mohammadian, Abdollah Mohammadian-Hafshejani, Hamid Salehiniya
    Annals of Global Health.2017; 82(5): 726.     CrossRef
  • The Effects of Physical Activity and Body Fat Mass on Colorectal Polyp Recurrence in Patients with Previous Colorectal Cancer
    Jihye Park, Jae Hyun Kim, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Jae Hee Cheon, Won Ho Kim, Ji Soo Park, Justin Y. Jeon, Tae Il Kim
    Cancer Prevention Research.2017; 10(8): 478.     CrossRef
Original Article
Intestinal obstruction: predictor of poor prognosis in colorectal carcinoma?
Mohd Azri Mohd Suan, Wei Leong Tan, Shahrul Aiman Soelar, Ibtisam Ismail, Muhammad Radzi Abu Hassan
Epidemiol Health. 2015;37:e2015017.   Published online March 30, 2015
DOI: https://doi.org/10.4178/epih/e2015017
  • 59,437 View
  • 184 Download
  • 10 Web of Science
  • 13 Crossref
AbstractAbstract PDF
Abstract
OBJECTIVES
The goal of this study was to assess the relationship between intestinal obstruction and the prognosis of colorectal carcinoma.
METHODS
Data pertaining to 4,501 colorectal carcinoma patients were extracted from the national colorectal registry and analysed. Survival analysis was performed using the Kaplan-Meier method. The log-rank test was used to compare the survival rate between patients with intestinal obstruction and those without intestinal obstruction. The p-values<0.05 were considered to indicate statistical significance. Simple Cox proportional hazards regression analysis was used to estimate the crude hazard ratio of mortality from colorectal cancer.
RESULTS
Intestinal obstruction was reported in more than 13% of patients. The 3-year survival rate after treatment was 48.3% (95% confidence interval [CI], 43.9 to 52.8) for patients with intestinal obstruction (n=593) and 54.9% (95% CI, 53.1 to 56.6) for patients without intestinal obstruction (n=3,908). The 5-year survival rate for patients with intestinal obstruction was 37.3% (95% CI, 31.9 to 42.8), which was lower than that of patients without intestinal obstruction (45.6%; 95% CI, 43.5 to 47.7). After adjusting the hazard ratio for other prognostic variables, intestinal obstruction had a statistically significant negative correlation with the survival rate of colorectal cancer patients, with an adjusted hazard ratio of 1.22 (p=0.008).
CONCLUSIONS
The presence of intestinal obstruction is associated with a lower survival rate among colorectal cancer patients.
Summary

Citations

Citations to this article as recorded by  
  • A Novel Clinical Nomogram for Predicting Overall Survival in Patients with Emergency Surgery for Colorectal Cancer
    Georgiana Bianca Constantin, Dorel Firescu, Raul Mihailov, Iulian Constantin, Ioana Anca Ștefanopol, Daniel Andrei Iordan, Bogdan Ioan Ștefănescu, Rodica Bîrlă, Eugenia Panaitescu
    Journal of Personalized Medicine.2023; 13(4): 575.     CrossRef
  • Colorectal Liver Metastases: A Literature Review of Viable Surgical Options with a Special Focus on Microwave Liver Thermal Ablation and Mini-Invasive Approach
    Michele Finotti, Francesco Enrico D’Amico, Maurizio Romano, Marco Brizzolari, Michele Scopelliti, Giacomo Zanus
    Journal of Personalized Medicine.2022; 13(1): 33.     CrossRef
  • A nomogram model for predicting prognosis of obstructive colorectal cancer
    Jian Lv, Yuan yuan Liu, Yi tao Jia, Jing li He, Guang yao Dai, Peng Guo, Zhao long Zhao, Yan ni Zhang, Zhong xin Li
    World Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • A Comparison of Emergency First Presentations of Colorectal Cancer in Under–50 and Over–50 Year-Old Patients
    Prateush Singh, Krashna Patel, Pallavi Arya, Esha Singh, Amitabh Mishra
    Journal of Investigative Surgery.2020; 33(6): 514.     CrossRef
  • Survival Status and Predictors of Mortality Among Colorectal Cancer Patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Retrospective Follow-up Study
    Bantalem Tilaye Atinafu, Fekadu Aga Bulti, Tefera Mulugeta Demelew
    Journal of Cancer Prevention.2020; 25(1): 38.     CrossRef
  • CR-Possum—Can It Be Used to Predict Morbidity? A Single-Centre Retrospective Study
    Viswakumar Prabakaran, Thamizhmathi Thangaraju, Anil C. Mathew, Vimalkumar Govindan, Vignesh Kannan, Tracy Rosalin Poulose
    Indian Journal of Surgical Oncology.2019; 10(1): 174.     CrossRef
  • Clinical Implications of Lymph Node Metastasis in Colorectal Cancer: Current Status and Future Perspectives
    Hye Jin Kim, Gyu–Seog Choi
    Annals of Coloproctology.2019; 35(3): 109.     CrossRef
  • Efficacy of 18-fluoro deoxy glucose-positron emission tomography computed tomography for the detection of colonic neoplasia proximal to obstructing colorectal cancer
    Daisuke Hojo, Toshiaki Tanaka, Miwako Takahashi, Koji Murono, Shigenobu Emoto, Manabu Kaneko, Kazuhito Sasaki, Kensuke Otani, Takeshi Nishikawa, Keisuke Hata, Kazushige Kawai, Toshimitsu Momose, Hiroaki Nozawa
    Medicine.2018; 97(31): e11655.     CrossRef
  • Kolorektal Kanserde Endoskopik Özelliklerler Tümör Patolojisini ve Tümör Evresini Predikte Edebilir mi?
    Muhammet Yener AKPINAR, Metin UZMAN, Zeynep GÖKTAŞ, Gülçin Güler ŞİMŞEK, Evrim KAHRAMANOĞLU AKSOY, Ferdane SAPMAZ, Yaşar NAZLIGÜL
    Endoskopi Gastrointestinal.2018; 26(3): 84.     CrossRef
  • The possibilities to improve the outcomes in patients with colon cancer complicated by acute obstruction
    Z. V. Totikov, V. Z. Totikov
    Khirurgiya. Zhurnal im. N.I. Pirogova.2017; (3): 17.     CrossRef
  • Colectomie par laparoscopie ou par laparotomie pour tumeur colique droite en occlusion : revue systématique de la littérature et méta-analyse
    R. Cirocchi, F.C. Campanile, S. Di Saverio, G. Popivanov, L. Carlini, D. Pironi, R. Tabola, N. Vettoretto
    Journal de Chirurgie Viscérale.2017; 154(6): 399.     CrossRef
  • Laparoscopic versus open colectomy for obstructing right colon cancer: A systematic review and meta-analysis
    R. Cirocchi, F. Cesare Campanile, S. Di Saverio, G. Popivanov, L. Carlini, D. Pironi, R. Tabola, N. Vettoretto
    Journal of Visceral Surgery.2017; 154(6): 387.     CrossRef
  • Advances in adjuvant therapy of colon cancer
    Santosh Kumar, Marcus S. Noel, Alok A. Khorana
    Seminars in Colon and Rectal Surgery.2016; 27(4): 204.     CrossRef
Epidemiol Health : Epidemiology and Health
© Korean Society of Epidemiology.